These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 12414539)

  • 1. Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
    Sousa MM; Fernandes R; Palha JA; Taboada A; Vieira P; Saraiva MJ
    Am J Pathol; 2002 Nov; 161(5):1935-48. PubMed ID: 12414539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
    Cardoso I; Saraiva MJ
    FASEB J; 2006 Feb; 20(2):234-9. PubMed ID: 16449795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
    Cardoso I; Goldsbury CS; Müller SA; Olivieri V; Wirtz S; Damas AM; Aebi U; Saraiva MJ
    J Mol Biol; 2002 Apr; 317(5):683-95. PubMed ID: 11955017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
    Sousa MM; Cardoso I; Fernandes R; Guimarães A; Saraiva MJ
    Am J Pathol; 2001 Dec; 159(6):1993-2000. PubMed ID: 11733349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
    Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J
    Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.
    Yi S; Takahashi K; Naito M; Tashiro F; Wakasugi S; Maeda S; Shimada K; Yamamura K; Araki S
    Am J Pathol; 1991 Feb; 138(2):403-12. PubMed ID: 1992765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters.
    Cardoso I; Merlini G; Saraiva MJ
    FASEB J; 2003 May; 17(8):803-9. PubMed ID: 12724338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
    João Saraiva M; Mendes Sousa M; Cardoso I; Fernandes R
    J Mol Neurosci; 2004; 23(1-2):35-40. PubMed ID: 15126690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
    Murakami T; Sango K; Watabe K; Niimi N; Takaku S; Li Z; Yamamura K; Sunada Y
    J Neurochem; 2015 Jul; 134(1):66-74. PubMed ID: 25693163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.
    Araki S; Yi S; Murakami T; Watanabe S; Ikegawa S; Takahashi K; Yamarnura K
    Mol Neurobiol; 1994 Feb; 8(1):15-23. PubMed ID: 8086125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
    Ferreira N; Saraiva MJ; Almeida MR
    PLoS One; 2012; 7(1):e29933. PubMed ID: 22253829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
    Liu J; Lan J; Zhao P; Zheng F; Song J; Zhang P; Sun X
    Int J Clin Exp Pathol; 2014; 7(11):7795-800. PubMed ID: 25550818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.
    Takaoka Y; Ohta M; Miyakawa K; Nakamura O; Suzuki M; Takahashi K; Yamamura K; Sakaki Y
    Am J Pathol; 2004 Jan; 164(1):337-45. PubMed ID: 14695346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
    Lee YJ; Oh J; Hwang SK; Lee EJ; Yang DH; Kim YJ; Kwon S; Hyun MC
    Neuropediatrics; 2019 Oct; 50(5):322-326. PubMed ID: 31319424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
    Wei L; Kawano H; Fu X; Cui D; Ito S; Yamamura K; Ishihara T; Tokuda T; Higuchi K; Maeda S
    Amyloid; 2004 Jun; 11(2):113-20. PubMed ID: 15478467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application to transthyretin analysis].
    Ueda M; Ando Y
    Rinsho Byori; 2006 Jun; 54(6):601-8. PubMed ID: 16872010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
    Magalhães J; Saraiva MJ
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1097-106. PubMed ID: 22082661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.